CB07-Exatecan, CAS 2879247-31-9

Product Description: CB07-Exatecan is an ADC drug-Linker conjugate that can be used for the synthesis of ADCs. ADC conjugated with CB07-Exatecan and trastuzumab inhibits the growth of HER2-positive cancer cells. CB07-Exatecan can be used in cancer research[1].

Applications: Cancer-programmed cell death

Formula: C71H94FN11O22

References: [1]Weijia Tang, et al. Method for treating her2-positive solid tumor. Patent WO2023198079A1.

CAS Number: 2879247-31-9

Molecular Weight: 1472.56

Compound Purity: 98.97

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Drug-Linker Conjugates for ADC;Topoisomerase

• SKU: MEXHY-160015-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-160015-5
• Package Unit: 5 mg
• Quantity Unit: STK